PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
Dosing Buprenorphine in the Fentanyl Era
Addiction MedsDisordersMedicationsOpioidsResearchSubstance Use

Dosing Buprenorphine in the Fentanyl Era

August 3, 2026by Chris Aiken, MD2
How Naltrexone-Bupropion Treats Meth Use Disorder
Addiction MedsDepressionDisordersMethamphetamineResearchSubstance Use

How Naltrexone-Bupropion Treats Meth Use Disorder

July 29, 2026by Chris Aiken, MD0
Ketamine for Addiction
Addiction MedsAlcoholCocaineDisordersKetamineMedicationsOpioidsResearchSubstance Use

Ketamine for Addiction

July 24, 2026by Chris Aiken, MD0
How to Personalize Meds for Alcohol Use Disorder
Addiction MedsAlcoholDisordersMed-PsychResearchSubstance Use

How to Personalize Meds for Alcohol Use Disorder

July 23, 2026by Chris Aiken, MD0
Buprenorphine vs Naltrexone: A Large Study
Addiction MedsMedicationsOpioidsResearchSubstance Use

Buprenorphine vs Naltrexone: A Large Study

July 15, 2026by Chris Aiken, MD0
New Guidelines For Substance Use Disorders
Addiction MedsAlcoholCannabisDisordersMethamphetamineOpioidsResearchSedativesSubstance Use

New Guidelines For Substance Use Disorders

July 12, 2026by Chris Aiken, MD2
Matching Opioid MAT for Complex Patients
Addiction MedsDisordersMed-PsychOpioidsResearchSubstance Use

Matching Opioid MAT for Complex Patients

July 10, 2026by Chris Aiken, MD0
Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal
Addiction MedsAlcoholDisordersMedicationsResearchSubstance Use

Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal

June 13, 2026by Chris Aiken, MD0
One Med Stands Out in Re-Analysis of Cocaine Use Disorder
Addiction MedsCocaineMedicationsMethamphetamineResearchSubstance UseTop Research

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

June 8, 2026by Chris Aiken, MD0
FDA Moves the Goalposts on Alcohol Treatment
Addiction MedsAlcoholResearchSubstance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0
Naltrexone-Baclofen Combo for Alcohol Craving
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1
Mirtazapine Reduces Meth Use
Addiction MedsMethamphetamineResearchTop Research

Mirtazapine Reduces Meth Use

April 2, 2026by Chris Aiken, MD2
Low Dose Naltrexone in Depression
Addiction MedsDepressionInflammationResearch

Low Dose Naltrexone in Depression

March 23, 2026by Chris Aiken, MD0
A New Combination Pill for Alcohol Use Disorder
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

A New Combination Pill for Alcohol Use Disorder

July 10, 2024by Chris Aiken, MD0
Employment
Top Studies
All Studies
Self Help

Recent Posts

  • August 13, 2026New Criteria for Postpartum Psychosis

  • August 12, 2026A Looming Crisis for Psychiatry Residency

  • August 12, 2026Creatine's Modest Boost to Memory and Mood

  • August 12, 2026The Missing Page in DSM

  • August 12, 2026New Hope for Treatment-Resistant Anxiety

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image